The widely recognized model for AD progression suggests that Aβ pathogenesis may be an upstream event in AD and functions as a trigger of downstream pathways, including the tau-mediated toxicity, misfolding of hyperphosphorylated tau isoforms, tau accumulation in tangles, and proliferation of tau proteins leading to cortical neurodegeneration [5]. This evidence concerns the gene MAPT and Alzheimer disease.